| Literature DB >> 28899658 |
Carryn J Chetty1, Eloise Ferreira1, Katarina Jovanovic1, Stefan F T Weiss2.
Abstract
The 37kDa/67kDa laminin receptor (LRP/LR) serves various physiological and pathological roles such as enhancing tumour-related processes including metastasis, angiogenesis, cellular viability and telomerase activation in cancerous cell lines. The present study investigates the effect of siRNA mediated downregulation of LRP/LR on pancreatic cancer (AsPC-1) and neuroblastoma (IMR-32) cells. MTT and BrdU assays revealed that siRNA mediated downregulation of LRP resulted in a significant reduction in cell viability and cell proliferation. In addition, knock-down of LRP resulted in phosphatidylserine externalization, diminished nuclear integrity and significantly enhanced caspase-3 activity, which is indicative of apoptosis. LRP downregulation resulted in a significant increase in caspase-8 activity in IMR-32 cells and enhanced caspase-8 and 9 activity in AsPC-1 cells. These data recommend siRNA mediated knock-down of LRP as a potential therapeutic avenue for the treatment of pancreatic cancer and neuroblastoma.Entities:
Keywords: 37kDa/67kDa laminin Receptor; Apoptosis; Neuroblastoma; Pancreatic cancer; Small interfering RNAs
Mesh:
Substances:
Year: 2017 PMID: 28899658 DOI: 10.1016/j.yexcr.2017.09.016
Source DB: PubMed Journal: Exp Cell Res ISSN: 0014-4827 Impact factor: 3.905